Psychedelic substances showing therapeutic promise

Researchers are finding that psychedelic substances like LSD, psilocybin mushrooms, and MDMA are proving to be effective at treating cancer-related anxiety and post-traumatic stress disorder. There was a major conference exploring the topic in California recently that was attended by some 1,200 people, and patients who have undergone psychedelic therapy sessions are reporting marked improvement in their mental outlook. A case in point is cancer patient Nicky Edlich, who is 67-years-old and suffering from anxiety because of her illness. She had never used psychedelics recreationally during her lifetime, but is buoyed by the results of her session.

“The world was made up of jewels and I was in a dome…this most incredible luminescence that made everything even more beautiful.” She says that overall she saw “how beautiful the world could actually be.”

Many people forget that the way that Timothy Leary began his experiments with psilocybin mushrooms and LSD was as a government sanctioned researcher at Harvard. The potential for psychedelics as a psychotherapeutic aid has long been known, and there is now a resurgence in interest and subsequent research. Recent studies at Johns Hopkins affirmed the positive impact that patients reported from a single session under the influence of psilocybin mushrooms, including a closer connection to divinity and overall improved behavior even many months after having the experience.

You can read more about the positive impact of psychedelics by clicking the link below.

Therapeutic Use of Psychedelics